Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
CYRAMZA (ramucirumab) is a recombinant human IgG1 monoclonal antibody that specifically binds to vascular endothelial growth factor receptor 2. ramucirumab has an approximate molecular weight of 147 kDa. ramucirumab is produced in genetically engineered mammalian CHO cells.
Ramucirumab is supplied at a concentration of 10 mg/mL as a sterile, preservative-free, clear to slightly opalescent and colorless to slightly yellow solution of pH 6.0, which contains 9.98 mg/mL glycine, 0.65 mg/mL histidine, 1.22 mg/mL histidine monohydrochloride, 0.1 mg/mL polysorbate 80, 4.383 mg/mL sodium chloride, and Water for Injection.
Properties
Name | Ramucirumab |
CAS NO. | 947687-13-0 |
Type | Whole antibody |
Source | Human |
Target | VEGFR2 (KDR) |
Clone | Monoclone |
Molecular Weight | 147 kDa |
Formula | C6374H9864N1692O1996S46 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China (Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Ramucirumab
